Birchview Capital as of Dec. 31, 2025
Portfolio Holdings for Birchview Capital
Birchview Capital holds 68 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kla Corporation Com New (KLAC) | 15.6 | $27M | 22k | 1215.08 | |
| Bristol Myers Squibb (BMY) | 9.6 | $16M | 303k | 53.94 | |
| Compass Therapeutics (CMPX) | 5.0 | $8.6M | 1.6M | 5.37 | |
| Stoke Therapeutics (STOK) | 4.8 | $8.3M | 260k | 31.74 | |
| Lam Research Corporation Com New (LRCX) | 4.0 | $6.9M | 40k | 171.18 | |
| Olema Pharmaceuticals (OLMA) | 3.9 | $6.7M | 269k | 25.00 | |
| Structure Therapeutics Spons Adr (GPCR) | 3.7 | $6.3M | 90k | 69.55 | |
| Protagonist Therapeutics (PTGX) | 2.8 | $4.8M | 55k | 87.34 | |
| ACADIA Pharmaceuticals (ACAD) | 2.7 | $4.6M | 171k | 26.71 | |
| Encana Corporation (OVV) | 2.5 | $4.2M | 108k | 39.19 | |
| Prothena Corp SHS (PRTA) | 2.5 | $4.2M | 441k | 9.55 | |
| Solid Biosciences Com New (SLDB) | 2.3 | $4.0M | 706k | 5.64 | |
| Neurocrine Biosciences (NBIX) | 2.3 | $3.9M | 27k | 141.83 | |
| Amicus Therapeutics (FOLD) | 2.1 | $3.6M | 253k | 14.24 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 1.9 | $3.3M | 463k | 7.08 | |
| Phathom Pharmaceuticals (PHAT) | 1.9 | $3.2M | 195k | 16.59 | |
| Castle Biosciences (CSTL) | 1.8 | $3.1M | 81k | 38.90 | |
| Intellia Therapeutics (NTLA) | 1.7 | $2.8M | 315k | 8.99 | |
| Immunome (IMNM) | 1.6 | $2.8M | 130k | 21.48 | |
| Corcept Therapeutics Incorporated (CORT) | 1.4 | $2.3M | 67k | 34.80 | |
| Vera Therapeutics Cl A (VERA) | 1.3 | $2.2M | 44k | 50.64 | |
| Quidel Corporation | 1.2 | $2.1M | 73k | 28.56 | |
| Novocure Ord Shs (NVCR) | 1.2 | $2.0M | 152k | 12.93 | |
| Biodesix | 1.1 | $2.0M | 287k | 6.80 | |
| Cytokinetics (CYTK) | 1.1 | $1.9M | 30k | 63.54 | |
| Phreesia (PHR) | 1.1 | $1.9M | 111k | 16.92 | |
| EQT Corporation (EQT) | 1.1 | $1.9M | 35k | 53.60 | |
| Harrow Health (HROW) | 1.0 | $1.7M | 34k | 49.00 | |
| Travere Therapeutics (TVTX) | 1.0 | $1.6M | 43k | 38.21 | |
| Foghorn Therapeutics (FHTX) | 0.9 | $1.5M | 282k | 5.40 | |
| United Therapeutics Corporation (UTHR) | 0.9 | $1.5M | 3.0k | 487.25 | |
| Ultragenyx Pharmaceutical (RARE) | 0.8 | $1.4M | 62k | 23.00 | |
| Alkermes SHS (ALKS) | 0.8 | $1.4M | 50k | 27.98 | |
| Nektar Therapeutics (NKTR) | 0.8 | $1.3M | 31k | 42.28 | |
| Apogee Therapeutics (APGE) | 0.7 | $1.2M | 16k | 75.48 | |
| Verastem Com New (VSTM) | 0.7 | $1.2M | 150k | 7.72 | |
| Axsome Therapeutics (AXSM) | 0.6 | $1.1M | 6.1k | 182.64 | |
| Masimo Corporation (MASI) | 0.6 | $1.1M | 8.3k | 130.06 | |
| 10x Genomics Inc Cl A (TXG) | 0.6 | $962k | 59k | 16.31 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $941k | 21k | 44.82 | |
| Pacific Biosciences of California (PACB) | 0.5 | $935k | 500k | 1.87 | |
| Kalvista Pharmaceuticals (KALV) | 0.5 | $921k | 57k | 16.15 | |
| Freeport-mcmoran Cl-b CL-B (FCX) | 0.5 | $917k | 18k | 50.79 | |
| Ventyx Biosciences (VTYX) | 0.5 | $911k | 101k | 9.03 | |
| Pharvaris N V (PHVS) | 0.5 | $828k | 30k | 27.75 | |
| Illumina (ILMN) | 0.5 | $787k | 6.0k | 131.16 | |
| Uniqure Nv SHS (QURE) | 0.4 | $737k | 31k | 23.93 | |
| Halozyme Therapeutics (HALO) | 0.4 | $680k | 10k | 67.30 | |
| Biohaven Pharmaceutical Holding | 0.4 | $670k | 59k | 11.29 | |
| Bridgebio Pharma (BBIO) | 0.4 | $665k | 8.7k | 76.49 | |
| Treace Med Concepts (TMCI) | 0.3 | $556k | 227k | 2.45 | |
| Pulmonx Corp (LUNG) | 0.3 | $554k | 251k | 2.21 | |
| Rapt Therapeutics Com New (RAPT) | 0.3 | $508k | 15k | 33.87 | |
| Gossamer Bio (GOSS) | 0.3 | $428k | 138k | 3.10 | |
| Alphatec Holdings (ATEC) | 0.2 | $380k | 18k | 21.04 | |
| Outset Med | 0.2 | $367k | 99k | 3.71 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $352k | 14k | 25.12 | |
| Liquidia Technologies (LQDA) | 0.2 | $345k | 10k | 34.49 | |
| Candel Therapeutics (CADL) | 0.2 | $339k | 60k | 5.65 | |
| Voyager Therapeutics (VYGR) | 0.2 | $294k | 75k | 3.93 | |
| Trinity Cap (TRIN) | 0.2 | $293k | 20k | 14.65 | |
| Inhibrx Biosciences (INBX) | 0.2 | $292k | 3.7k | 79.00 | |
| Kayne Anderson Bdc Com Shs (KBDC) | 0.2 | $286k | 20k | 14.32 | |
| Cullinan Oncology (CGEM) | 0.1 | $207k | 20k | 10.35 | |
| Aziyo Biologics (ELUT) | 0.1 | $182k | 263k | 0.69 | |
| Alumis (ALMS) | 0.1 | $98k | 10k | 9.76 | |
| Docgo (DCGO) | 0.0 | $44k | 50k | 0.88 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.0 | $23k | 17k | 1.35 |